PROJECT: Banta Healthcare Group (BHG)
PROJECT: A global $45 million Tier I metal fabricator
in the automotive, heavy truck, construction,
agriculture, motorcycle, and general industrial markets
Optimize Operations team lead by: David L. Gurbach, President
ISSUES
• Supply Chain
• International Product Line Startup
• Product Line Expansion
• Team Organization and Management
• Good Manufacturing Practices (GMP)
I knew we needed strong, hands-on leadership with an outstanding track record and recruited Dave as the perfect candidate for this role. He proved me right. Dave oversaw the integration of a major strategic acquisition, which quadrupled the size of the Healthcare Group, and he acted quickly by building a solid management team, identifying key issues and positioning the business for future growth. In addition, he introduced a new Asia (China) supply chain model to the Healthcare operation and the Corporation.
OPTIMIZE OPERATIONS SOLUTION
BHG was the single source supplier to Zeiss Corporation of microscope drapes, a Class 2 medical device. Annual sales exceeded $5 million with very attractive margins. Extreme pricing pressure from an offshore source resulted in a need to transition the manufacturing and production of the product to a lower cost platform. Banta Corporation’s Mexico JV partner, Grupo Imagan, although primarily a printing company, managed a small healthcare business located in Mexico City and was identified as a possible future source for the product. A management decision was made to transfer the existing production cell from its Wisconsin location to Mexico City. The team quickly responded and successfully transitioned the product platform to Mexico within six months, and moved the device through FDA approval within a 12-month timeframe.
This decisive and proactive approach enabled the business unit to maintain the very high-profile Zeiss business, meet the customer’s pricing targets and maintain an attractive level of profitability for BHG stakeholders.
DELIVERABLES
1) Transparent product quality and performance
2) Lower cost margin and profit protection
3) FDA approval (fast tracked)
4) Maintain Zeiss account